Form 4 for ONCO Onconetix, Inc.
Accepted 2025-03-25 00:00:00 ET · period of report 2025-03-23 · accession 0001013762-25-002105 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-25 | 2025-03-23 | ONCO | Oakley Andrew John | Dir | A - Grant | $0.00 | +1,709 | 1,709 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-23 | A | A | 1,709 | $0.00 | 1,709 | D | — | — | (F1) On March 23, 2025, the Reporting Person was granted 1,709 restricted stock units, which will be settled in shares of common stock, par value $0.00001. The restricted stock units fully vest on August 31, 2025. (F2) Includes unvested RSUs. |